Day One Biopharmaceuticals, Inc. (DAWN)

DAWN Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35.62	124.97	230.78	85.26	284.31	43.73
Short-Term Investments	417.48	406.75	135.56	257.01	-	-
Cash & Short-Term Investments	453.1	531.72	366.35	342.27	284.31	43.73
Cash Growth	25.21%	45.14%	7.03%	20.39%	550.18%	59.99%
Receivables	19.67	13.88	-	-	-	-
Inventory	6.54	3.32	-	-	-	-
Prepaid Expenses	5.59	5.2	3.27	2.6	2.96	0.08
Other Current Assets	9.52	8.22	5.66	3.01	2.1	1.26
Total Current Assets	494.43	562.33	375.27	347.87	289.37	45.07
Property, Plant & Equipment	4.82	4.71	0.56	0.72	0.28	0.48
Other Intangible Assets	19.61	15.63	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.04
Other Long-Term Assets	0.18	0.12	0.21	0.47	0.17	0.07
Total Assets	519.04	582.79	376.05	349.06	289.82	45.66
Accounts Payable	5.09	3.26	2.58	0.26	1.74	0.2
Accrued Expenses	44.13	56.46	25.48	15.77	6.61	1.57
Current Portion of Leases	0.15	0.01	0.41	0.41	0.2	0.2
Current Unearned Revenue	1.85	1.55	-	-	-	-
Other Current Liabilities	-	12.16	1.04	0.18	0.1	0.03
Total Current Liabilities	51.22	73.45	29.51	16.62	8.66	2
Long-Term Leases	2.85	2.59	-	0.41	0.02	0.2
Long-Term Unearned Revenue	3.37	3.23	-	-	-	-
Other Long-Term Liabilities	0.76	0.76	-	-	-	-
Total Liabilities	58.2	80.04	29.51	17.02	8.67	2.2
Common Stock	0.01	0.01	0.01	0.01	0.01	2
Additional Paid-In Capital	1,081	1,057	805.11	601.77	408.63	-
Retained Earnings	-620.4	-554.08	-458.59	-269.67	-127.49	-56.84
Comprehensive Income & Other	-0.09	0.08	0.01	-0.07	-	0.64
Total Common Equity	460.83	502.75	346.54	332.04	281.15	-54.21
Minority Interest	-	-	-	-	-	5.7
Shareholders' Equity	460.83	502.75	346.54	332.04	281.15	43.46
Total Liabilities & Equity	519.04	582.79	376.05	349.06	289.82	45.66
Total Debt	3	2.6	0.41	0.81	0.22	0.4
Net Cash (Debt)	450.1	529.12	365.94	341.46	284.09	43.33
Net Cash Growth	24.45%	44.59%	7.17%	20.19%	555.70%	58.52%
Net Cash Per Share	4.45	5.68	4.59	5.22	7.69	7.84
Filing Date Shares Outstanding	102.43	101.35	87.38	73.59	61.95	2.6
Total Common Shares Outstanding	102.43	101.12	87.23	73.46	61.95	2.6
Working Capital	443.21	488.88	345.77	331.26	280.71	43.08
Book Value Per Share	4.50	4.97	3.97	4.52	4.54	-20.88
Tangible Book Value	441.22	487.12	346.54	332.04	281.15	-54.21
Tangible Book Value Per Share	4.31	4.82	3.97	4.52	4.54	-20.88
Machinery	-	-	-	-	0.08	0.08
Leasehold Improvements	-	-	-	-	0.02	0.02

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q